Company Overview - Profusa, Inc. is a commercial stage digital health company based in Berkeley, California, focused on developing tissue-integrated sensors for continuous monitoring of biochemistry [4] - The company aims to provide affordable, long-lasting, injectable biosensors that transmit actionable medical-grade data for personal and medical use [4] Business Combination - Profusa announced the closing of its business combination with NorthView Acquisition Corp. (NVAC), which was approved by NVAC's shareholders on June 9, 2025 [1] - The combined company will operate under the name Profusa, Inc., with common stock expected to begin trading on Nasdaq under the ticker symbol "PFSA" starting July 14, 2025 [1] - A secured convertible promissory note was issued to an institutional investor, raising $9 million to cover transaction costs and support future working capital needs, with a total of up to $20 million available under the convertible note facility [2] Technology and Vision - Profusa's technology platform is designed to continuously monitor and transmit body chemistries to smartphone applications, leveraging advanced data analytics and AI technologies [2] - The company aims to improve health management for chronic diseases such as diabetes, critical limb ischemia (CLI), and peripheral arterial disease (PAD) [2] Leadership and Support - The company is led by a visionary scientific team and an experienced management group, supported by dedicated employees, partners, and investors [2]

Core Insights - Theodore Blegen, EVP and CFO of Monolithic Power Systems, executed an open market sale of 6,000 shares valued at $4.5 million on July 2, 2025, which is significantly larger than his typical trading activity [1][3][11] Group 1: Transaction Details - The transaction involved the sale of 6,000 shares, with a total value of $4.5 million, reported on July 2, 2025 [2] - Post-transaction, Blegen retains 46,939 shares, valued at approximately $34.8 million [5] - The sale occurred at a price 7.02% above the 50-day moving average and 9.95% above the 200-day moving average as of July 10, 2025 [4] Group 2: Company Overview - Monolithic Power Systems has a market capitalization of $35.45 billion, trailing twelve-month revenue of $2.21 billion, and a net income of $1.79 billion [7] - The company specializes in semiconductor-based power electronics solutions, including DC to DC integrated circuits, serving various markets such as computing, automotive, and consumer electronics [8][10] Group 3: Insider Trading Context - Blegen's recent sale is more than three times his median trade size of 1,884 shares, indicating an unusually large transaction [3] - This sale marks Blegen's first reported trade in 140 days, contrasting with his historical average of 14.8 trades per year, suggesting a lower trading frequency recently [6] - The timing of the sale aligns with a previous pause in trading activity, which may have been influenced by stock price fluctuations [11][14] Group 4: Market Performance - Monolithic Power Systems has consistently surpassed analysts' consensus targets for over three years, despite a recent stock price drop due to modest guidance targets [13] - The stock has seen a 24% price increase year-to-date, and it is currently valued at 19.5 times earnings, indicating reasonable valuation [14]

Company Overview - TechnipFMC plc is a leading manufacturer and supplier of products, services, and fully integrated technology solutions for the energy industry, formed from the merger of Technip and FMC Technologies in January 2017 [12] - The company focuses on designing, producing, and servicing technologically sophisticated systems and products for subsea, onshore/offshore, and surface projects, aiming to enhance the performance of its oil and gas clients [12] Investment Analysis - TechnipFMC has a Zacks Rank of 3 (Hold) and a VGM Score of B, indicating a solid position in the market [13] - The company has a Value Style Score of B, supported by attractive valuation metrics such as a forward P/E ratio of 17.07, which may appeal to value investors [13] - For fiscal 2025, three analysts have revised their earnings estimates upwards in the last 60 days, with the Zacks Consensus Estimate increasing to $2.07 per share [13] - TechnipFMC has demonstrated an average earnings surprise of +37.2%, suggesting potential for positive performance [13] - With a solid Zacks Rank and top-tier Value and VGM Style Scores, TechnipFMC is recommended for investors' consideration [14]

Broadcom TodayAVGOBroadcom$272.37 -3.03 (-1.10%) 52-Week Range$128.50▼$281.18Dividend Yield0.87%P/E Ratio102.23Price Target$290.21Add to WatchlistAI semiconductor giant Broadcom NASDAQ: AVGO recently found its biggest bull on Wall Street yet. On June 24, analysts at HSBC issued a massive $400 price target on the stock. Compared to Broadcom’s July 9 closing price of just under $278, HSBC’s price target indicates that shares could rise by another 44%. So, what is driving HSBC to issue such an optimistic targ ...

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Centene class action lawsuit – captioned Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.) – seeks to represent purchasers or acquirers of Centene Corporation (NYSE: CNC) securities and charges Centene and certain of Centene’s executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Centene class act ...

ATLANTA, July 11, 2025 (GLOBE NEWSWIRE) -- LNG Alliance Pte Ltd (“LNG Alliance”), an integrated provider of LNG export terminal infrastructure and LNG supply, has announced its strategic decision to select Chart Industries' (NYSE: GTLS) (“Chart”) IPSMR® (Integrated Pre-cooled Single Mixed Refrigerant) process technology and modular liquefaction solution for its Amigo LNG export facility with a capacity of 7.8 MTPA in Guaymas, Sonora, Mexico. Chart Industries' cutting-edge IPSMR® process technology sets the ...

Core Viewpoint - 10x Genomics, Inc. will report its financial results for Q2 2025 on August 7, 2025, and will host a conference call to discuss these results and future outlook [1]. Group 1: Financial Reporting - The financial results for the second quarter ended June 30, 2025, will be announced after market close on August 7, 2025 [1]. - A public conference call and live webcast for analysts and investors will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time [1]. Group 2: Company Overview - 10x Genomics is a life science technology company focused on products that enhance the understanding of biology and improve human health [3]. - The company offers integrated research solutions, including instruments, consumables, and software for single cell and spatial biology, aiding researchers in comprehending complex biological systems [3]. - Its products contribute to advancements in various fields such as oncology, immunology, and neuroscience, leading to significant discoveries in health and disease [3]. Group 3: Disclosure Practices - 10x Genomics utilizes various channels, including SEC filings, press releases, and social media, to disclose material non-public information and comply with disclosure obligations [4].

The artificial intelligence boom may be just getting started.Tech stocks have led the charge off the April lows as this bull market enters its next phase. Semiconductor stocks and related companies remain at the heart of the movement.Astera Labs has been a major beneficiary. The company designs and manufactures semiconductor-based connectivity solutions for cloud and AI infrastructure. Astera offers an intelligent connectivity platform and high-speed connectivity integrated circuits as well as modules, boar ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style Sco ...

Core Viewpoint - JB Hunt (JBHT) is expected to report quarterly earnings of $1.34 per share, a 1.5% increase year-over-year, with revenues forecasted at $2.96 billion, reflecting a 1.1% year-over-year increase [1]. Earnings Estimates - The consensus EPS estimate has been revised downward by 0.7% over the past 30 days, indicating a collective reassessment by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock performance [3]. Revenue Projections - Analysts project 'Revenue- Truckload' at $163.94 million, indicating a year-over-year decrease of 2.5% [4]. - 'Revenue- Dedicated' is expected to reach $849.27 million, reflecting a slight decrease of 0.2% from the previous year [5]. - 'Revenue- Final Mile Services' is estimated at $219.08 million, showing a year-over-year decline of 6.9% [5]. - 'Revenue- Integrated Capacity Solutions' is forecasted to be $272.18 million, indicating a 0.7% increase from the prior year [5]. Key Metrics - The consensus for 'Dedicated - Average trucks during the period' is 12,624, down from 13,142 year-over-year [6]. - 'Integrated Capacity Solutions - Revenue per load' is projected at $1,949.26, compared to $1,860.00 last year [6]. - 'Intermodal - Revenue per load' is expected to be $2,797.39, down from $2,829.00 year-over-year [6]. - 'Intermodal - Trailing equipment (end of period)' is estimated at 125,792, up from 121,169 last year [7]. - 'Final Mile Services - Average trucks during the period' is projected at 1,347, down from 1,374 year-over-year [7]. Load Estimates - 'Integrated Capacity Solutions - Loads' is expected to be 140,866, down from 145,362 last year [8]. - 'Intermodal - Loads' is forecasted at 523,353, an increase from 497,446 in the same quarter last year [8]. - 'Truckload - Loads' is projected to reach 94,663, up from 92,628 year-over-year [8]. Stock Performance - Over the past month, JB Hunt shares have returned +8.4%, outperforming the Zacks S&P 500 composite's +4.4% change [9]. - JBHT holds a Zacks Rank 4 (Sell), indicating a likely underperformance compared to the overall market in the upcoming period [9].